Effects of a Personalized Nurse-Led Educational Program for New Patients Receiving Oral Anticoagulant Therapy after Mechanical Heart Valve Prosthesis Implantation on Adherence to Treatment [PDF]
Background: Life-long anticoagulant therapy is mandatory for patients who undergo heart valve replacement with implantation of a mechanical prosthesis.
Rokeia Eltheni+3 more
doaj +10 more sources
Transcatheter aortic valve‐in‐valve implantation of a corevalve in a degenerated stenotic sapien heart valve prosthesis [PDF]
Treatment options for re‐stenotic aortic valve prosthesis implanted by transcatheter technique have not been evaluated systematically. We describe the case of a 75‐year‐old dialysis patient who was treated by transcatheter aortic valve implantation 3.5 years ago and now presented with severe stenosis of the percutaneous heart valve.
Rainer Hoffmann+2 more
semanticscholar +5 more sources
This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent.
Fabrice Bauer+10 more
semanticscholar +5 more sources
Advances in the diagnosis and management of congenital heart disease (CHD) have resulted in an increased number of patients living into adulthood. Despite increased survival, these patients often require surgery at a young age and are susceptible to developing complications related to the degeneration of surgical prostheses and valves.
Clare Rayner+3 more
+6 more sources
German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation—Outcomes of the MYLAND (MYvaL germAN stuDy) Study [PDF]
Background: The primary objective of this study was to evaluate the initial experience in Germany with the Meril Myval™ (MM) transcatheter heart valve (THV) system for the treatment of severe symptomatic aortic valve stenosis. The MM THV is a novel balloon-expandable valve with an expanded sizing matrix.
Timm Ubben+9 more
openaire +4 more sources
The pandemic changed the type of patients. The concept of “patient at the center” became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The “Heart Team” model is on increasing affirmation.
Manes, Maria Teresa+6 more
openaire +4 more sources
Transcatheter Aortic Valve Implantation in Alkaptonuria-Аssociated Severe Aortic Stenosis: A 2.5-Year Follow-Up Case Report and Literature Review [PDF]
Introduction: Alkaptonuria is an autosomal-recessive disorder affecting the metabolism of tyrosine and phenylalanine which results in accumulation of homogentisic acid in connective tissues.
Spas Kitov+5 more
doaj +2 more sources
Early Structural Valve Deterioration and Cusp Tear Leading to Acute Heart Failure in a Second-Generation Trifecta Glide Technology Heart Valve [PDF]
This report highlights a case of early structural valve deterioration with a cusp tear in a second-generation Abbott Trifecta Glide Technology bioprosthetic heart valve.
Akiyoshi Yamamoto, MD+3 more
doaj +2 more sources
A certain degree of prosthesis oversizing (OS) is recommended for the SAPIEN 3 to achieve device success. However, an increase in OS may increase permanent pacemaker implantation (PPI) rates. We therefore investigated the influence of OS on device failure and PPI.A total of 804 patients were treated with SAPIEN 3 at 3 centers.
Heribert Schunkert+18 more
openaire +6 more sources
Background: Prosthesis sizing in transcatheter aortic valve replacement (TAVR) uses certain prosthesis oversizing (OS) to achieve device success. However, an increase in OS may increase the need for permanent pacemaker implantations (PPI).
Albert M. Kasel+15 more
openaire +3 more sources